Roche Raises Bid For Genentech

Roche Raises Bid for Genentech

Swiss drug company Roche Holding increased its offer to acquire the rest of Genentech to $93 a share from $86.50.

Sections:  news   business   
RELATED ARTICLES
  • Microsoft may buy Barnes & Noble's Nook unit for $1 billion
    According to internal documents obtained by the website TechCrunch, Microsoft has offered $1 billion for the digital assets of Nook Media, Barnes & Noble's digital book venture. According to internal documents obtained by the website TechCrunch, Microsoft has offered $1 billion for the digital assets of Nook Media, Barnes & Noble's digital book venture. More
  • Bayer to pay $1.1B for California firm Conceptus
    Germany drug company Bayer AG says it intends to buy California-based Conceptus to expand its birth control offerings. Bayer said Monday it would launch a pupublicblic offer to pay $31.00 per share for all the stock in Conceptus, Inc. That means Bayer would pay $1.1 billion. More
  • Cancer Physicians Attack High Drug Costs
    More than 100 cancer specialists have banded together to persuade pharmaceutical companies to bring prices down, suggesting that the high prices for medicine needed to keep someone alive is profiteering. More
  • Swedish police find drugs on Bieber tour bus
    The latest chapter in Justin Bieber's European tour escapade was added Thursday when Swedish police said they had found drugs and a stun gun on the pop singer's bus. Lars Bystrom, spokesman for the Stockholm police, told The Associated Press a small amount of drugs and a stun gun were discovered during a search of the bus, which had been parked under the Globen concert venue in Stockholm, where Bieber was performing Wednesday. More
  • Dish's $25.5 billion Sprint bid may force others to act
    Dish Network Corp, the No. 2 U.S. satellite television provider, on Monday offered to buy wireless service provider Sprint Nextel Corp for $25.5 billion in cash and stock, a move that could inspire other telecommunications or video companies to consider their own prospects of combining. More
BING NEWS:
  • Swiss firm Roche bid to prevent India’s Natco Pharma from introducing cheap spinal drug
    An attempt by Roche, a Swiss pharmaceuticals firm, to prevent India’s Natco Pharma from introducing a generic version of a medicine for spinal muscular atrophy (SMA) will deny patients access to ...
    11/5/2024 - 5:11 pm | View Link
  • AbbVie’s Deal for Alzheimer’s Antibody Raises Curtain for Roche News on Wednesday
    AbbVie’s Deal for Alzheimer’s Antibody Raises Curtain for Roche News on Wednesday The transaction, seen as a vote of confidence, has put the focus on other drug firms testing similar barrier ...
    10/31/2024 - 10:25 am | View Link
  • AbbVie’s Deal for Alzheimer’s Antibody Raises Curtain for Roche News on Wednesday
    Chief among them is Roche Holding: Wednesday morning it will report interim Phase 2 results for its antibody trontinemab, which promises to be the best Alzheimer’s treatment so far. The Lilly ...
    10/29/2024 - 10:38 am | View Link
  • Swiss start-up Noema raises $59m to develop neurology drugs offloaded by Roche
    Swiss biotech Noema has raised 54 million Swiss francs ($59m) to develop four neurological disorder drugs licensed in from Roche. The company is developing four phase 2 drugs brought in from Roche ...
    12/1/2020 - 11:00 am | View Link
  • More

 

Comment On This Story

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News